NeuroTherm Acquires Smith & Nephew Interventional Spine Pain Management Assets

Thursday, April 8, 2010 Press Release
Email Print This Page Comment bookmark
Font : A-A+

Purchase further expands NeuroTherm's reach into the $5 Billion Global Interventional Pain Medicine Market

WILMINGTON, Mass., April 7 /PRNewswire/ -- NeuroTherm announced today that they have acquired the Smith & Nephew

PLC (NYSE: SNN; LSE: SN) Interventional Spine Pain Management assets from Smith & Nephew's subsidiaries.  The acquired product line includes several innovative interventional spine pain products including the CDS Discography System, SPINECATH™ & ACUTHERM™ Catheters and a full radiofrequency product line.  NeuroTherm will also be a distributor of the TRUCATH™ Injection System within the Interventional Spine Pain market.

To view the multimedia assets associated with this release, please click

(Logo: )

"This acquisition made perfect sense for us, and will go a long way towards sustaining NeuroTherm's leading position in the interventional pain space," says Larry Hicks, President & CEO of NeuroTherm.  "The Smith & Nephew product line is highly complementary to ours and significantly expands our product offering.  This is an exciting opportunity that will enable us to offer a one-stop option for our customers," continues Hicks.

"We have set plans in place to combine the experience and product knowledge of the two worldwide sales teams to allow us to provide our global customer base with excellent products and a single point of contact," says Jos Kerstens, VP of International Sales.  NeuroTherm actively sells interventional pain products into 58 countries around the world.  "We remain focused on helping physicians expand their practice and offer improved patient care to patients who suffer from chronic pain," continues Kerstens.  

NeuroTherm is a leading manufacturer of products used in the field of Interventional Pain, including radio frequency generators and related consumables used to treat chronic pain.  The company was awarded a US Patent #7,574,257 in recognition of the first multi-lesion radiofrequency generator launch.  NeuroTherm markets and sells to Interventional Pain, Interventional Radiology, Orthopedic and Foot & Ankle Specialists. Foot & Ankle Physicians use radiofrequency to treat pain associated with Plantar Fasciitis & Neuroma.

NeuroTherm is headquartered in Wilmington, Massachusetts with corporate offices in London and Amsterdam.  Additional information about NeuroTherm can be found on at

Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management.  Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives.  The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust.  The Company operates in 32 countries around the world. Annual sales in 2009 were $3.8 billion.

SOURCE NeuroTherm


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store